Mitochondria and ageing
Humanin
Editorial audit: October 15, 2026 · draft; scientific, medical and translation review pending
01What is reported
Humanin is described in anti-aging and mitochondrial combinations with repeated systemic dosing claims.
02Proposed rationale
Cell-survival signaling and endogenous associations motivate research. These findings do not establish that external administration improves lifespan.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
03What the research shows
The audited mechanistic work is preclinical. Human associations, where discussed, are not trials of the guide’s injection regimen.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
04Limits and unknowns
The source’s dose summaries are internally inconsistent. Do not resolve the conflict by choosing the more familiar number or averaging the tables.
NOT A RECOMMENDATION.Each amount is attributed to the source identified for that entry: regulatory product labeling, human research, or community and practice sources. These source categories have different evidentiary roles. They are not medical advice, not a protocol, not a recommended or safe dose, and not evidence that it works. Do not use them to start, change or stop any treatment. Talk to a qualified healthcare professional.
05Questions to ask about the product
Confirm exact peptide or analogue and treat conflicting numeric claims as unresolved source issues.
06Open research question
Which claims derive from endogenous measurements versus actual administration, and can they be cataloged separately?
Primary and regulatory references
- 1.